JP2002510966A - 自動蛋白質デザインのための装置および方法 - Google Patents
自動蛋白質デザインのための装置および方法Info
- Publication number
- JP2002510966A JP2002510966A JP54410998A JP54410998A JP2002510966A JP 2002510966 A JP2002510966 A JP 2002510966A JP 54410998 A JP54410998 A JP 54410998A JP 54410998 A JP54410998 A JP 54410998A JP 2002510966 A JP2002510966 A JP 2002510966A
- Authority
- JP
- Japan
- Prior art keywords
- protein
- sequence
- rotamers
- residues
- rotamer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1089—Design, preparation, screening or analysis of libraries using computer algorithms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/003—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by transforming the C-terminal amino acid to amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B15/00—ICT specially adapted for analysing two-dimensional or three-dimensional molecular structures, e.g. structural or functional relations or structure alignment
- G16B15/20—Protein or domain folding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/50—Mutagenesis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Medical Informatics (AREA)
- Theoretical Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Evolutionary Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.プログラムの制御下でコンピューターによって実行される方法であって、 該コンピューターは該プログラムを保存するためのメモリーを含み、該方法は、 (A)可変残基位置を持つ蛋白質骨格構造を受領し; (B)該可変残基位置の各々について可能なロタマーの群を確立し、ここに、 少なくとも1つの可変残基位置は少なくとも2つの異なるアミノ酸側鎖からのロ タマーを有し;次いで、 (C)該ロタマーの各々と該蛋白質骨格構造の残りの全てまたは一部との相互 作用を解析して、最適化蛋白質配列のセットを生成させ、ここに、該分析工程は デッドエンド排除(DEE)計算を含む; 工程を含むことを特徴とする該方法。 2.プログラムの制御下でコンピューターによって実行される方法であって、 該コンピューターは該プログラムを保存するためのメモリーを含み、該方法は、 (A)可変残基位置を持つ蛋白質骨格構造を受領し; (B)各可変残基位置をコア、表面または境界残基に分類し、 (C)該可変残基位置の各々について可能なロタマーの群を確立し、ここに、 少なくとも1つの可変残基位置は少なくとも2つの異なるアミノ酸側鎖からのロ タマーを有し;次いで、 (D)該ロタマーの各々と該蛋白質骨格構造の残りの全てまたは一部との相互 作用を解析して、最適化蛋白質配列のセットを生成させる; 工程を含むことを特徴とする該方法。 3.該解析工程がDEE計算を含む請求項2記載の方法。 4.最適化蛋白質配列の該セットが全体最適蛋白質配列を含む請求項1または 2記載の方法。 5.該DEE計算がオリジナルのDEEおよびゴールドシュティン(Goldstei n)DEEよりなる群から選択される請求項1または3記載の方法。 6.該解析工程が少なくとも1つのスコアリング機能の使用を含む請求項1ま たは2記載の方法。 7.該スコアリング機能がファンデルワールスポテンシャルスコアリング機能 、水素結合ポテンシャルスコアリング機能、原子溶媒和スコアリング機能、静電 スコアリング機能および二次構造特性スコアリング機能よりなる群から選択され る請求項6記載の方法。 8.該解析工程が少なくとも2つのスコアリング機能を含む請求項6記載の方 法。 9.該解析工程が少なくとも3つのスコアリング機能を含む請求項6記載の方 法。 10.該解析工程が少なくとも4つのスコアリング機能を含む請求項6記載の 方法。 11.さらに、少なくとも1つの数の該セットをテストして、実験結果を生じ させることを含む請求項1または2記載の方法。 12.さらに、(D)該全体最適蛋白質配列からさらなる最適配列のランク付 けされたリストを生成させることを含む請求項4記載の方法。 13.該生成がモンテカルロサーチの使用を含む請求項12記載の方法。 14.該解析工程がモンテカルロ計算を含む請求項2記載の方法。 15.さらに、(E)該ランク付けリストからの該蛋白質配列のいくつかまた は全てをテストして、ポテンシャルエネルギーテスト結果を得ることを含む請求 項12記載の方法。 16.さらに、(F)該ポテンシャルエネルギーテスト結果および理論的ポテ ンシャルエネルギーデータの間の対応性を解析することを含む請求項15記載の 方法。 17.請求項1または2の方法によって生成した最適化蛋白質。 18.請求項17記載の蛋白質配列をコードする核酸配列。 19.請求項18記載の核酸を含む発現ベクトル。 20.請求項18記載の核酸を含む宿主細胞。 21.公知の蛋白質配列から少なくとも約5%異なり、公知の蛋白質配列より も少なくとも20%安定である配列を有する蛋白質。 22.蛋白質骨格モデルの残基位置についての潜在的ロタマーの群を修正する ための側鎖モジュール; 該ロタマーの各々と該蛋白質の残りの全てまたは一部との相互作用を解析して 最適化蛋白質配列のランキングモジュール; を含むコンピューターを指令して特異的に機能させるコンピューター解読可能な メモリー。 23.該ランキングモジュールがファンデルワールススコアリング機能成分を 含む請求項22記載のコンピューター解読可能メモリー。 24.該ランキングモジュールが原子溶媒和スコアリング機能成分を含む請求 項22記載のコンピューター解読可能メモリー。 25.該ランキングモジュールが水素結合スコアリング機能成分を含む請求項 22記載のコンピューター解読可能メモリー。 26.該ランキングモジュールが二次構造スコアリング機能成分を含む請求項 22記載のコンピューター解読可能メモリー。 27.さらに、ポテンシャルエネルギーテスト結果および理論的ポテンシャル エネルギーデータの間の対応性を評価するための接近可能モジュールを含む請求 項22記載のコンピューター解読可能メモリー。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4346497P | 1997-04-11 | 1997-04-11 | |
US60/043,464 | 1997-04-11 | ||
US5467897P | 1997-08-04 | 1997-08-04 | |
US60/054,678 | 1997-08-04 | ||
US6109797P | 1997-10-03 | 1997-10-03 | |
US60/061,097 | 1997-10-03 | ||
PCT/US1998/007254 WO1998047089A1 (en) | 1997-04-11 | 1998-04-10 | Apparatus and method for automated protein design |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002510966A true JP2002510966A (ja) | 2002-04-09 |
Family
ID=27366337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54410998A Ceased JP2002510966A (ja) | 1997-04-11 | 1998-04-10 | 自動蛋白質デザインのための装置および方法 |
Country Status (8)
Country | Link |
---|---|
US (11) | US6188965B1 (ja) |
EP (1) | EP0974111B1 (ja) |
JP (1) | JP2002510966A (ja) |
AU (1) | AU751331B2 (ja) |
CA (1) | CA2286262A1 (ja) |
DE (1) | DE69810603T2 (ja) |
DK (1) | DK0974111T3 (ja) |
WO (1) | WO1998047089A1 (ja) |
Families Citing this family (191)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7047171B1 (en) * | 1995-12-08 | 2006-05-16 | Sproch Norman K | Method for the characterization of the three-dimensional structure of proteins employing mass spectrometric analysis and computational feedback modeling |
US20060277017A1 (en) * | 1993-11-04 | 2006-12-07 | Sproch Norman K | Method for the characterization of the three-dimensional structure of proteins employing mass spectrometric analysis and computational feedback modeling |
DE69810603T2 (de) * | 1997-04-11 | 2003-11-13 | California Inst Of Techn | Gerät und verfahren für automatischen protein-entwurf |
US6403312B1 (en) | 1998-10-16 | 2002-06-11 | Xencor | Protein design automatic for protein libraries |
US7315786B2 (en) * | 1998-10-16 | 2008-01-01 | Xencor | Protein design automation for protein libraries |
US20030049654A1 (en) * | 1998-10-16 | 2003-03-13 | Xencor | Protein design automation for protein libraries |
US20020048772A1 (en) * | 2000-02-10 | 2002-04-25 | Dahiyat Bassil I. | Protein design automation for protein libraries |
JP2003527072A (ja) * | 1998-10-16 | 2003-09-16 | ゼンコー | 蛋白質ライブラリーに関する蛋白質設計オートメーション |
US7208473B2 (en) | 1999-01-06 | 2007-04-24 | Xencor, Inc. | Nucleic acids and protein variants of hG-CSF with granulopoietic activity |
WO2000040728A1 (en) * | 1999-01-06 | 2000-07-13 | Xencor, Inc. | Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |
US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US6917882B2 (en) * | 1999-01-19 | 2005-07-12 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
EP1151409A1 (en) * | 1999-01-18 | 2001-11-07 | Maxygen, Inc. | Methods of populating data stuctures for use in evolutionary simulations |
US20070065838A1 (en) * | 1999-01-19 | 2007-03-22 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
EP1108783A3 (en) | 1999-01-19 | 2001-09-05 | Maxygen, Inc. | Oligonucleotide-mediated nucleic acid recombination |
US7024312B1 (en) | 1999-01-19 | 2006-04-04 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
US7702464B1 (en) | 2001-08-21 | 2010-04-20 | Maxygen, Inc. | Method and apparatus for codon determining |
US6961664B2 (en) | 1999-01-19 | 2005-11-01 | Maxygen | Methods of populating data structures for use in evolutionary simulations |
US8457903B1 (en) | 1999-01-19 | 2013-06-04 | Codexis Mayflower Holdings, Llc | Method and/or apparatus for determining codons |
US7873477B1 (en) | 2001-08-21 | 2011-01-18 | Codexis Mayflower Holdings, Llc | Method and system using systematically varied data libraries |
US6864359B1 (en) | 1999-02-11 | 2005-03-08 | Xencor | Structure-based screening techniques for drug discovery |
WO2000047612A2 (en) * | 1999-02-11 | 2000-08-17 | Xencor, Inc. | Structure-based screening techniques for drug discovery |
JP3892167B2 (ja) * | 1999-03-19 | 2007-03-14 | 富士通株式会社 | 粒子集団の配置を生成する生成装置および方法 |
US6343257B1 (en) | 1999-04-23 | 2002-01-29 | Peptor Ltd. | Identifying pharmacophore containing combinations of scaffold molecules and substituents from a virtual library |
US6946265B1 (en) | 1999-05-12 | 2005-09-20 | Xencor, Inc. | Nucleic acids and proteins with growth hormone activity |
US6682923B1 (en) | 1999-05-12 | 2004-01-27 | Xencor | Thermostable alkaliphilic xylanase |
EP1179075A2 (en) * | 1999-05-12 | 2002-02-13 | Xencor, Inc. | Bacillus circulans xylanase mutants |
EP1177297A2 (en) * | 1999-05-12 | 2002-02-06 | Xencor Inc. | Novel nucleic acids and proteins with growth hormone activity |
US6514729B1 (en) * | 1999-05-12 | 2003-02-04 | Xencor, Inc. | Recombinant interferon-beta muteins |
US6334099B1 (en) * | 1999-05-25 | 2001-12-25 | Digital Gene Technologies, Inc. | Methods for normalization of experimental data |
EP1222603A2 (en) * | 1999-09-01 | 2002-07-17 | California Institute of Technology | Methods and compositions utilizing a branch and terminate algorithm for protein design |
US7430477B2 (en) * | 1999-10-12 | 2008-09-30 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
WO2001033438A2 (en) * | 1999-11-03 | 2001-05-10 | Algonomics Nv | Method for generating information related to the molecular structure of a biomolecule |
US8229721B1 (en) | 1999-11-03 | 2012-07-24 | Lonza Biologics Plc | Apparatus and method for structure-based prediction of amino acid sequences |
JP2003524831A (ja) * | 1999-11-22 | 2003-08-19 | イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム | 組み合わせ空間を探索するためのシステムおよび方法 |
JP3964087B2 (ja) * | 1999-12-24 | 2007-08-22 | 株式会社カネカ | 多重変異蛋白質アミノ酸配列の最適化解を算出する方法、装置、およびこの方法の処理を実行するプログラムを記憶する記憶媒体 |
US7462354B2 (en) * | 1999-12-28 | 2008-12-09 | Pharmexa Inc. | Method and system for optimizing minigenes and peptides encoded thereby |
EP1621617A1 (en) * | 2000-02-10 | 2006-02-01 | Xencor, Inc. | Protein design automation for protein libraries |
CA2399839A1 (en) * | 2000-02-10 | 2001-08-16 | Xencor | Protein design automation for protein libraries |
US20070172449A1 (en) * | 2000-03-02 | 2007-07-26 | Xencor, Inc. | TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS |
US7101974B2 (en) | 2000-03-02 | 2006-09-05 | Xencor | TNF-αvariants |
US7687461B2 (en) | 2000-03-02 | 2010-03-30 | Xencor, Inc. | Treatment of TNF-α related disorders with TNF-α variant proteins |
US7662367B2 (en) * | 2000-03-02 | 2010-02-16 | Xencor, Inc. | Pharmaceutical compositions for the treatment of TNF-α related disorders |
US7446174B2 (en) | 2001-03-02 | 2008-11-04 | Xencor, Inc. | Protein based TNF-α variants for the treatment of TNF-α related disorders |
US7244823B2 (en) * | 2000-03-02 | 2007-07-17 | Xencor | TNF-alpha variants proteins for the treatment of TNF-alpha related disorders |
WO2001064889A2 (en) * | 2000-03-02 | 2001-09-07 | Xencor | Tnf-alpha variants for the treatment of tnf-alpha related disorders |
US7056695B2 (en) | 2000-03-02 | 2006-06-06 | Xencor | TNF-α variants |
US6983233B1 (en) | 2000-04-19 | 2006-01-03 | Symyx Technologies, Inc. | Combinatorial parameter space experiment design |
WO2001090960A2 (en) * | 2000-05-24 | 2001-11-29 | California Institute Of Technology | Methods for protein design |
US6586207B2 (en) * | 2000-05-26 | 2003-07-01 | California Institute Of Technology | Overexpression of aminoacyl-tRNA synthetases for efficient production of engineered proteins containing amino acid analogues |
DE10028875A1 (de) * | 2000-06-10 | 2001-12-20 | Hte Gmbh | Rechnergestützte Optimierung von Substanzbibliotheken |
AU2001282880A1 (en) | 2000-07-07 | 2002-01-21 | California Institute Of Technology | Proteins with integrin-like activity |
US20020119492A1 (en) * | 2000-07-10 | 2002-08-29 | Chirino Arthur J. | Protein design automation for designing protein libraries with altered immunogenicity |
IL137886A0 (en) | 2000-08-16 | 2001-10-31 | Univ Ramot | A novel algorithm for de novo protein design |
AU2001280077A1 (en) * | 2000-08-16 | 2002-02-25 | Ramot University Authority For Applied Research And Industrial Development Ltd. | Method and system for predicting amino acid sequence |
AU2002230784A1 (en) * | 2000-11-10 | 2002-05-21 | Xencor | Novel thermostable alkaliphilic xylanase |
US6996550B2 (en) * | 2000-12-15 | 2006-02-07 | Symyx Technologies, Inc. | Methods and apparatus for preparing high-dimensional combinatorial experiments |
US20030036854A1 (en) * | 2001-02-06 | 2003-02-20 | The Penn State Research Foundation | Apparatus and method for designing proteins and protein libraries |
US7231328B2 (en) * | 2001-02-06 | 2007-06-12 | The Penn State Research Foundation | Apparatus and method for designing proteins and protein libraries |
WO2003068907A2 (en) * | 2001-02-09 | 2003-08-21 | California Institute Of Technology | Method for the generation of proteins with new enzymatic function |
CA2440467A1 (en) * | 2001-03-12 | 2002-09-19 | Board Of Regents, University Of Texas System | Ensemble-based strategy for the design of protein pharmaceuticals |
JP2005512161A (ja) * | 2001-03-12 | 2005-04-28 | ボード オブ レジェンツ,ザ ユニバーシティー オブ テキサス システム | ペプチドおよびタンパク質の立体配座アンサンブルの列挙およびリガンド親和性分析のためのコンピュータベースのストラテジー |
JP2005505250A (ja) * | 2001-05-04 | 2005-02-24 | ゼンコー | 核酸およびチオレドキシンレダクターゼ活性を有するタンパク質 |
US20030211511A1 (en) * | 2001-05-04 | 2003-11-13 | Briggs Steven P. | Nucleic acids and proteins with thioredoxin reductase activity |
US20030049680A1 (en) * | 2001-05-24 | 2003-03-13 | Gordon D. Benjamin | Methods and compositions utilizing hybrid exact rotamer optimization algorithms for protein design |
US7110525B1 (en) | 2001-06-25 | 2006-09-19 | Toby Heller | Agent training sensitive call routing system |
US20030022285A1 (en) * | 2001-07-10 | 2003-01-30 | Chirino Arthur J. | Protein design automation for designing protein libraries with altered immunogenicity |
EP1482434A3 (en) * | 2001-08-10 | 2006-07-26 | Xencor, Inc. | Protein design automation for protein libraries |
US20030130827A1 (en) * | 2001-08-10 | 2003-07-10 | Joerg Bentzien | Protein design automation for protein libraries |
WO2003021498A2 (en) * | 2001-08-31 | 2003-03-13 | Optimum Power Technology, L.P. | Design optimization |
US6822073B2 (en) * | 2001-12-20 | 2004-11-23 | Kimberly-Clark Worldwide, Inc. | Modular peptide-based reagent |
US20040230380A1 (en) * | 2002-01-04 | 2004-11-18 | Xencor | Novel proteins with altered immunogenicity |
US7381792B2 (en) * | 2002-01-04 | 2008-06-03 | Xencor, Inc. | Variants of RANKL protein |
US7139665B2 (en) * | 2002-02-27 | 2006-11-21 | California Institute Of Technology | Computational method for designing enzymes for incorporation of non natural amino acids into proteins |
WO2003074679A2 (en) * | 2002-03-01 | 2003-09-12 | Xencor | Antibody optimization |
US7662925B2 (en) * | 2002-03-01 | 2010-02-16 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
US20080254027A1 (en) * | 2002-03-01 | 2008-10-16 | Bernett Matthew J | Optimized CD5 antibodies and methods of using the same |
US20070148171A1 (en) * | 2002-09-27 | 2007-06-28 | Xencor, Inc. | Optimized anti-CD30 antibodies |
US7317091B2 (en) * | 2002-03-01 | 2008-01-08 | Xencor, Inc. | Optimized Fc variants |
US8188231B2 (en) | 2002-09-27 | 2012-05-29 | Xencor, Inc. | Optimized FC variants |
US20080260731A1 (en) * | 2002-03-01 | 2008-10-23 | Bernett Matthew J | Optimized antibodies that target cd19 |
US20040132101A1 (en) * | 2002-09-27 | 2004-07-08 | Xencor | Optimized Fc variants and methods for their generation |
DE60229788D1 (de) * | 2002-03-26 | 2008-12-18 | Council Scient Ind Res | Verfahren und system zum erstellen von optimalen modellen für dreidimensionale, molekulare strukturen |
AU2003220559A1 (en) * | 2002-03-26 | 2003-10-13 | Carnegie Mellon University | Methods and systems for molecular modeling |
WO2003087310A2 (en) * | 2002-04-04 | 2003-10-23 | California Institute Of Technology | Directed protein docking algorithm |
US7272545B2 (en) * | 2002-05-22 | 2007-09-18 | General Electric Company | Method and apparatus for designing and locating chemical structures |
JP2006507562A (ja) * | 2002-05-23 | 2006-03-02 | ザ ボード オブ レジェンツ−ザ ユニバーシティー オブ テキサス システム | アンサンブルベースの構造エネルギーを使用した一塩基多型(snps)の意義の予測 |
EP1552295A4 (en) * | 2002-07-01 | 2007-11-28 | Johnson & Johnson Pharm Res | CONFORMATIONAL SAMPLING BY SELF-ORGANIZATION |
DE10233047A1 (de) * | 2002-07-19 | 2004-02-26 | Amaxa Gmbh | Verfahren zur Herstellung eines künstlichen Polypeptids und nach diesem Verfahren hergestelltes künstliches Protein |
US20040082783A1 (en) * | 2002-08-06 | 2004-04-29 | Schafmeister Christian E. | Bis (amino acid) molecular scaffolds |
US20060235208A1 (en) * | 2002-09-27 | 2006-10-19 | Xencor, Inc. | Fc variants with optimized properties |
CA2832136C (en) | 2002-09-27 | 2015-11-17 | Xencor | Optimized fc variants and methods for their generation |
US20040175359A1 (en) * | 2002-11-12 | 2004-09-09 | Desjarlais John Rudolph | Novel proteins with antiviral, antineoplastic, and/or immunomodulatory activity |
US20060014248A1 (en) * | 2003-01-06 | 2006-01-19 | Xencor, Inc. | TNF super family members with altered immunogenicity |
US20050221443A1 (en) * | 2003-01-06 | 2005-10-06 | Xencor, Inc. | Tumor necrosis factor super family agonists |
US20050130892A1 (en) * | 2003-03-07 | 2005-06-16 | Xencor, Inc. | BAFF variants and methods thereof |
US7553930B2 (en) * | 2003-01-06 | 2009-06-30 | Xencor, Inc. | BAFF variants and methods thereof |
ES2341648T3 (es) | 2003-01-20 | 2010-06-24 | Cambridge Enterprise Limited | Aparato y metodo informatizado para predecir la solubilidad o agregacion de un polipeptido. |
EP1593060A2 (en) * | 2003-01-21 | 2005-11-09 | The Trustees Of The University Of Pennsylvania | Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel kcsa |
US9818136B1 (en) | 2003-02-05 | 2017-11-14 | Steven M. Hoffberg | System and method for determining contingent relevance |
US20040176585A1 (en) * | 2003-02-27 | 2004-09-09 | Carter Richard J. | Method and system for determining optimal sequences |
US8084582B2 (en) | 2003-03-03 | 2011-12-27 | Xencor, Inc. | Optimized anti-CD20 monoclonal antibodies having Fc variants |
US20090010920A1 (en) * | 2003-03-03 | 2009-01-08 | Xencor, Inc. | Fc Variants Having Decreased Affinity for FcyRIIb |
US8388955B2 (en) | 2003-03-03 | 2013-03-05 | Xencor, Inc. | Fc variants |
US20070275460A1 (en) * | 2003-03-03 | 2007-11-29 | Xencor.Inc. | Fc Variants With Optimized Fc Receptor Binding Properties |
US7610156B2 (en) * | 2003-03-31 | 2009-10-27 | Xencor, Inc. | Methods for rational pegylation of proteins |
US7642340B2 (en) | 2003-03-31 | 2010-01-05 | Xencor, Inc. | PEGylated TNF-α variant proteins |
WO2004089421A2 (en) * | 2003-03-31 | 2004-10-21 | Xencor, Inc | Methods for rational pegylation of proteins |
US9051373B2 (en) | 2003-05-02 | 2015-06-09 | Xencor, Inc. | Optimized Fc variants |
EP1620548A2 (en) * | 2003-05-07 | 2006-02-01 | Duke University | Protein design for receptor-ligand recognition and binding |
WO2005014641A2 (en) * | 2003-07-09 | 2005-02-17 | Xencor, Inc. | Ciliary neurotrophic factor variants |
WO2005052839A2 (en) * | 2003-07-29 | 2005-06-09 | California Institute Of Technology | Systems and methods for predicting transmembrane domains in membrane proteins and mining the genome for recognizing g-protein coupled receptors |
WO2005017805A2 (en) * | 2003-08-13 | 2005-02-24 | California Institute Of Technology | Systems and methods for predicting the structure and function of multipass transmembrane proteins |
US20050065879A1 (en) * | 2003-09-18 | 2005-03-24 | Convergys Information Management Group, Inc. | System and method for web service billing |
US7765175B2 (en) * | 2003-09-18 | 2010-07-27 | Optimum Power Technology, L.P. | Optimization expert system |
US8101720B2 (en) | 2004-10-21 | 2012-01-24 | Xencor, Inc. | Immunoglobulin insertions, deletions and substitutions |
US9714282B2 (en) | 2003-09-26 | 2017-07-25 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
WO2005035564A2 (en) | 2003-10-10 | 2005-04-21 | Xencor, Inc. | Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
EP1673466B1 (en) * | 2003-10-14 | 2012-06-06 | Verseon | Method and apparatus for analysis of molecular combination based on computational estimation of electrostatic affinity using basis expansions |
US20070149496A1 (en) * | 2003-10-31 | 2007-06-28 | Jack Tuszynski | Water-soluble compound |
WO2005044087A2 (en) * | 2003-11-05 | 2005-05-19 | The Regents Of The University Of California | Methods for the determination of protein three-dimensional structure employing hydrogen exchange analysis to refine computational structure prediction |
GB0325817D0 (en) * | 2003-11-05 | 2003-12-10 | Univ Cambridge Tech | Method and apparatus for assessing polypeptide aggregation |
WO2005047520A2 (en) * | 2003-11-07 | 2005-05-26 | Dna Software, Inc. | System and methods for three dimensional molecular structural analysis |
US7574306B1 (en) * | 2003-11-20 | 2009-08-11 | University Of Washington | Method and system for optimization of polymer sequences to produce polymers with stable, 3-dimensional conformations |
EP2221315A1 (en) | 2003-12-04 | 2010-08-25 | Xencor, Inc. | Methods of generating variant proteins with increased host string content and compositions thereof |
US20060122783A1 (en) * | 2004-08-24 | 2006-06-08 | Ishikawa Muriel Y | System and method for heightening a humoral immune response |
US20060003412A1 (en) * | 2003-12-08 | 2006-01-05 | Xencor, Inc. | Protein engineering with analogous contact environments |
US20070249809A1 (en) * | 2003-12-08 | 2007-10-25 | Xencor, Inc. | Protein engineering with analogous contact environments |
EP1697520A2 (en) * | 2003-12-22 | 2006-09-06 | Xencor, Inc. | Fc polypeptides with novel fc ligand binding sites |
AU2005227326B2 (en) * | 2004-03-24 | 2009-12-03 | Xencor, Inc. | Immunoglobulin variants outside the Fc region |
US20050260711A1 (en) * | 2004-03-30 | 2005-11-24 | Deepshikha Datta | Modulating pH-sensitive binding using non-natural amino acids |
WO2005109158A2 (en) * | 2004-05-05 | 2005-11-17 | Massachusetts Institute Of Technology | Methods and systems for generating peptides |
US20050287639A1 (en) | 2004-05-17 | 2005-12-29 | California Institute Of Technology | Methods of incorporating amino acid analogs into proteins |
JP2008507591A (ja) * | 2004-05-21 | 2008-03-13 | ゼンコー・インコーポレイテッド | 免疫原性が改変されたC1qファミリーメンバータンパク質 |
US20150010550A1 (en) | 2004-07-15 | 2015-01-08 | Xencor, Inc. | OPTIMIZED Fc VARIANTS |
US20060074225A1 (en) * | 2004-09-14 | 2006-04-06 | Xencor, Inc. | Monomeric immunoglobulin Fc domains |
US20060136139A1 (en) * | 2004-10-12 | 2006-06-22 | Elcock Adrian H | Rapid computational identification of targets |
JP5227026B2 (ja) * | 2004-10-28 | 2013-07-03 | セルノ・バイオサイエンス・エルエルシー | 定性的なおよび定量的な質量スペクトル分析 |
US20070135620A1 (en) * | 2004-11-12 | 2007-06-14 | Xencor, Inc. | Fc variants with altered binding to FcRn |
US8546543B2 (en) | 2004-11-12 | 2013-10-01 | Xencor, Inc. | Fc variants that extend antibody half-life |
US8802820B2 (en) | 2004-11-12 | 2014-08-12 | Xencor, Inc. | Fc variants with altered binding to FcRn |
EP2314618A3 (en) | 2004-11-12 | 2011-10-19 | Xencor Inc. | Fc variants with altered binding to FcRn |
US8367805B2 (en) | 2004-11-12 | 2013-02-05 | Xencor, Inc. | Fc variants with altered binding to FcRn |
US20060275282A1 (en) * | 2005-01-12 | 2006-12-07 | Xencor, Inc. | Antibodies and Fc fusion proteins with altered immunogenicity |
US20080207467A1 (en) * | 2005-03-03 | 2008-08-28 | Xencor, Inc. | Methods for the design of libraries of protein variants |
WO2006094234A1 (en) * | 2005-03-03 | 2006-09-08 | Xencor, Inc. | Methods for the design of libraries of protein variants |
WO2007016319A2 (en) | 2005-07-29 | 2007-02-08 | Targeted Growth, Inc. | Dominant negative mutant krp protein protection of active cyclin-cdk complex inhibition by wild-type krp |
US20070212700A1 (en) * | 2005-09-07 | 2007-09-13 | The Board Of Regents Of The University Of Texas System | Methods of using and analyzing biological sequence data |
WO2007038414A2 (en) * | 2005-09-27 | 2007-04-05 | Indiana University Research & Technology Corporation | Mining protein interaction networks |
WO2007041635A2 (en) * | 2005-10-03 | 2007-04-12 | Xencor, Inc. | Fc variants with optimized fc receptor binding properties |
AU2006302254B2 (en) * | 2005-10-06 | 2011-05-26 | Xencor, Inc. | Optimized anti-CD30 antibodies |
ES2317819T1 (es) * | 2005-11-03 | 2009-05-01 | Redpoint Bio Corporation | Ensayo de deteccion de alto rendimiento para el canal ionico trpm5. |
US7739055B2 (en) * | 2005-11-17 | 2010-06-15 | Massachusetts Institute Of Technology | Methods and systems for generating and evaluating peptides |
ES2504521T3 (es) | 2006-03-03 | 2014-10-08 | California Institute Of Technology | Incorporación específica del sitio de aminoácidos en moléculas |
US20070208411A1 (en) * | 2006-03-06 | 2007-09-06 | Boston Scientific Scimed, Inc. | Bifurcated stent with surface area gradient |
US20070254307A1 (en) * | 2006-04-28 | 2007-11-01 | Verseon | Method for Estimation of Location of Active Sites of Biopolymers Based on Virtual Library Screening |
JP5313129B2 (ja) * | 2006-05-02 | 2013-10-09 | アロザイン, インコーポレイテッド | 非天然アミノ酸置換ポリペプチド |
US20080096819A1 (en) * | 2006-05-02 | 2008-04-24 | Allozyne, Inc. | Amino acid substituted molecules |
JP5448447B2 (ja) * | 2006-05-26 | 2014-03-19 | 国立大学法人京都大学 | ケミカルゲノム情報に基づく、タンパク質−化合物相互作用の予測と化合物ライブラリーの合理的設計 |
US7674594B2 (en) * | 2006-07-27 | 2010-03-09 | Redpoint Bio Corporation | Screening assay for inhibitors of TRPA1 activation by a lower alkyl phenol |
US8524867B2 (en) | 2006-08-14 | 2013-09-03 | Xencor, Inc. | Optimized antibodies that target CD19 |
JP5562031B2 (ja) * | 2006-09-18 | 2014-07-30 | ゼンコー・インコーポレイテッド | Hm1.24を標的とする最適化抗体 |
AU2008247815B2 (en) | 2007-05-02 | 2012-09-06 | Ambrx, Inc. | Modified interferon beta polypeptides and their uses |
US7580304B2 (en) * | 2007-06-15 | 2009-08-25 | United Memories, Inc. | Multiple bus charge sharing |
CA2707840A1 (en) | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
WO2009045377A2 (en) * | 2007-10-01 | 2009-04-09 | Redpoint Bio Corporation | A non-desensitizing mutant of the transient receptor potential trpm5 ion channel |
CN101918026B (zh) | 2007-11-20 | 2016-03-02 | Ambrx公司 | 经修饰胰岛素多肽和其用途 |
EP2235059B1 (en) | 2007-12-26 | 2015-02-18 | Xencor, Inc. | Fc variants with altered binding to fcrn |
WO2009149218A2 (en) * | 2008-06-03 | 2009-12-10 | Codon Devices, Inc. | Novel proteins and methods of designing and using same |
UA118536C2 (uk) | 2008-07-23 | 2019-02-11 | Амбркс, Інк. | Модифікований поліпептид бичачого гранулоцитарного колонієстимулювального фактора та його застосування |
WO2010080720A2 (en) | 2009-01-12 | 2010-07-15 | Nektar Therapeutics | Conjugates of a lysosomal enzyme moiety and a water soluble polymer |
US20120148604A1 (en) | 2009-08-20 | 2012-06-14 | Transposagen Biopharmaceuticals, Inc. | Trp inhibitors and uses thereof |
US9493578B2 (en) | 2009-09-02 | 2016-11-15 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
EP2516454A4 (en) | 2009-12-21 | 2013-05-22 | Ambrx Inc | MODIFIED BOVINE SOMATOTROPIN POLYPEPTIDES AND ITS USES |
NZ600363A (en) | 2009-12-21 | 2014-07-25 | Ambrx Inc | Modified porcine somatotropin polypeptides and their uses |
US8362210B2 (en) | 2010-01-19 | 2013-01-29 | Xencor, Inc. | Antibody variants with enhanced complement activity |
LT2605789T (lt) | 2010-08-17 | 2019-09-10 | Ambrx, Inc. | Modifikuoti relaksino polipeptidai ir jų panaudojimas |
TWI480288B (zh) | 2010-09-23 | 2015-04-11 | Lilly Co Eli | 牛顆粒細胞群落刺激因子及其變體之調配物 |
RS57919B1 (sr) | 2011-12-16 | 2019-01-31 | Poseida Therapeutics Inc | Trpc4 modulatori za primenu u lečenju ili prevenciji bola |
US20130252280A1 (en) * | 2012-03-07 | 2013-09-26 | Genformatic, Llc | Method and apparatus for identification of biomolecules |
US10025900B2 (en) | 2013-03-15 | 2018-07-17 | Arzeda Corp. | Automated method of computational enzyme identification and design |
CA2915953C (en) * | 2013-06-21 | 2023-03-14 | Zymeworks Inc. | Systems and methods for physical parameter fitting on the basis of manual review |
US10381326B2 (en) | 2014-05-28 | 2019-08-13 | Invensas Corporation | Structure and method for integrated circuits packaging with increased density |
US10988514B2 (en) | 2016-04-01 | 2021-04-27 | University Of Washington | Polypeptdes capable of forming homo-oligomers with modular hydrogen bond network-mediated specificity and their design |
MX2020006322A (es) | 2017-12-19 | 2020-09-18 | Xencor Inc | Proteinas de fusion il-2 fc modificadas. |
US20190325986A1 (en) * | 2018-04-24 | 2019-10-24 | Samsung Electronics Co., Ltd. | Method and device for predicting amino acid substitutions at site of interest to generate enzyme variant optimized for biochemical reaction |
SG11202102427XA (en) | 2018-09-11 | 2021-04-29 | Ambrx Inc | Interleukin-2 polypeptide conjugates and their uses |
US20220009986A1 (en) | 2018-10-19 | 2022-01-13 | Ambrx, Inc. | Interleukin-10 polypeptide conjugates, dimers thereof, and their uses |
AU2021233909A1 (en) | 2020-03-11 | 2022-09-29 | Ambrx, Inc. | Interleukin-2 polypeptide conjugates and methods of use thereof |
EP4002383A3 (en) * | 2020-11-13 | 2022-08-03 | Tokyo Institute of Technology | Information processing device, information processing method, recording medium recording information processing program, and information processing system |
CN114495243B (zh) * | 2022-04-06 | 2022-07-05 | 第六镜科技(成都)有限公司 | 图像识别模型训练及图像识别方法、装置、电子设备 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4939666A (en) * | 1987-09-02 | 1990-07-03 | Genex Corporation | Incremental macromolecule construction methods |
US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
US5265030A (en) * | 1990-04-24 | 1993-11-23 | Scripps Clinic And Research Foundation | System and method for determining three-dimensional structures of proteins |
US5241470A (en) * | 1992-01-21 | 1993-08-31 | The Board Of Trustees Of The Leland Stanford University | Prediction of protein side-chain conformation by packing optimization |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US5878373A (en) * | 1996-12-06 | 1999-03-02 | Regents Of The University Of California | System and method for determining three-dimensional structure of protein sequences |
GB9701425D0 (en) | 1997-01-24 | 1997-03-12 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
DE69810603T2 (de) * | 1997-04-11 | 2003-11-13 | California Inst Of Techn | Gerät und verfahren für automatischen protein-entwurf |
US20020048772A1 (en) * | 2000-02-10 | 2002-04-25 | Dahiyat Bassil I. | Protein design automation for protein libraries |
US20030049654A1 (en) * | 1998-10-16 | 2003-03-13 | Xencor | Protein design automation for protein libraries |
JP2003527072A (ja) | 1998-10-16 | 2003-09-16 | ゼンコー | 蛋白質ライブラリーに関する蛋白質設計オートメーション |
US7315786B2 (en) * | 1998-10-16 | 2008-01-01 | Xencor | Protein design automation for protein libraries |
US6403312B1 (en) * | 1998-10-16 | 2002-06-11 | Xencor | Protein design automatic for protein libraries |
EP1179075A2 (en) | 1999-05-12 | 2002-02-13 | Xencor, Inc. | Bacillus circulans xylanase mutants |
CA2399839A1 (en) | 2000-02-10 | 2001-08-16 | Xencor | Protein design automation for protein libraries |
US20030130827A1 (en) * | 2001-08-10 | 2003-07-10 | Joerg Bentzien | Protein design automation for protein libraries |
-
1998
- 1998-04-10 DE DE69810603T patent/DE69810603T2/de not_active Expired - Fee Related
- 1998-04-10 AU AU69654/98A patent/AU751331B2/en not_active Ceased
- 1998-04-10 CA CA002286262A patent/CA2286262A1/en not_active Abandoned
- 1998-04-10 WO PCT/US1998/007254 patent/WO1998047089A1/en active IP Right Grant
- 1998-04-10 DK DK98915478T patent/DK0974111T3/da active
- 1998-04-10 US US09/058,459 patent/US6188965B1/en not_active Expired - Lifetime
- 1998-04-10 EP EP98915478A patent/EP0974111B1/en not_active Expired - Lifetime
- 1998-04-10 JP JP54410998A patent/JP2002510966A/ja not_active Ceased
- 1998-07-31 US US09/127,926 patent/US6269312B1/en not_active Expired - Lifetime
-
2000
- 2000-11-15 US US09/714,357 patent/US6708120B1/en not_active Expired - Lifetime
-
2001
- 2001-03-19 US US09/812,034 patent/US6950754B2/en not_active Expired - Lifetime
- 2001-04-04 US US09/827,960 patent/US6801861B2/en not_active Expired - Lifetime
- 2001-04-18 US US09/837,886 patent/US6804611B2/en not_active Expired - Lifetime
-
2002
- 2002-01-25 US US10/057,552 patent/US6792356B2/en not_active Expired - Lifetime
-
2004
- 2004-07-09 US US10/888,748 patent/US20050038610A1/en not_active Abandoned
-
2005
- 2005-07-28 US US11/193,654 patent/US20060019316A1/en not_active Abandoned
-
2006
- 2006-07-21 US US11/491,351 patent/US20070032961A1/en not_active Abandoned
- 2006-07-21 US US11/491,279 patent/US20060259247A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0974111B1 (en) | 2003-01-08 |
US6188965B1 (en) | 2001-02-13 |
DK0974111T3 (da) | 2003-04-22 |
US6269312B1 (en) | 2001-07-31 |
US20070032961A1 (en) | 2007-02-08 |
AU6965498A (en) | 1998-11-11 |
US6801861B2 (en) | 2004-10-05 |
US20020004706A1 (en) | 2002-01-10 |
US6792356B2 (en) | 2004-09-14 |
US6708120B1 (en) | 2004-03-16 |
DE69810603D1 (de) | 2003-02-13 |
US20060019316A1 (en) | 2006-01-26 |
US20060259247A1 (en) | 2006-11-16 |
AU751331B2 (en) | 2002-08-15 |
US6950754B2 (en) | 2005-09-27 |
US20010032052A1 (en) | 2001-10-18 |
US20050038610A1 (en) | 2005-02-17 |
EP0974111A1 (en) | 2000-01-26 |
CA2286262A1 (en) | 1998-10-22 |
US20020106694A1 (en) | 2002-08-08 |
US20010039480A1 (en) | 2001-11-08 |
DE69810603T2 (de) | 2003-11-13 |
WO1998047089A1 (en) | 1998-10-22 |
US6804611B2 (en) | 2004-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002510966A (ja) | 自動蛋白質デザインのための装置および方法 | |
Poma et al. | Combining the MARTINI and structure-based coarse-grained approaches for the molecular dynamics studies of conformational transitions in proteins | |
De Bakker et al. | Ab initio construction of polypeptide fragments: Accuracy of loop decoy discrimination by an all‐atom statistical potential and the AMBER force field with the Generalized Born solvation model | |
Wang et al. | Development of polarizable models for molecular mechanical calculations I: parameterization of atomic polarizability | |
Kapoor et al. | The carboxylation status of osteocalcin has important consequences for its structure and dynamics | |
Gunasekaran et al. | Sequence and structural analysis of cellular retinoic acid‐binding proteins reveals a network of conserved hydrophobic interactions | |
Basit et al. | Calcium ion binding to the mutants of calmodulin: a structure-based computational predictive model of binding affinity using a charge scaling approach in molecular dynamics simulation | |
Cui et al. | Polarizable force field of intrinsically disordered proteins with CMAP and reweighting optimization | |
Durdagi et al. | Atomistic models for free energy evaluation of drug binding to membrane proteins | |
Santini et al. | Rational design of glycosaminoglycan binding cyclic peptides using cPEPmatch | |
Worth et al. | Use of multiple molecular dynamics trajectories to study biomolecules in solution: the YTGP peptide | |
Profantova et al. | Protonation effect of tyrosine in a segment of the SRF transcription factor: A combined optical spectroscopy, molecular dynamics, and density functional theory calculation study | |
Zou et al. | Local interactions that contribute minimal frustration determine foldability | |
Rakhmanov et al. | Atomic hydration potentials using a Monte Carlo Reference State (MCRS) for protein solvation modeling | |
Dwevedi | Protein folding: Examining the challenges from synthesis to folded form | |
Gong et al. | A holistic molecular docking approach for predicting protein-protein complex structure | |
Wang et al. | An atomic radii set and Generalized Born implicit solvation model trained using explicit water solvation free energy data | |
Roitberg | A molecular dynamics study of Fe2S2 putidaredoxin: multiple conformations of the C-terminal region | |
Mokoena | Computational studies of the folding patterns of small and medium-size polypeptides | |
Karpusenka | Free Energy and Structure of Helix-forming Peptides: A theoretical investigation | |
Leis | Impact of Protein conformational Changes on Molecular Docking-Design of a Docking Approach including Receptor Flexibility | |
Stultz et al. | Fragment docking to proteins with the multi-copy simultaneous search methodology | |
Li | Computational protein design: assessment and applications | |
Eisenman et al. | Structure and selectivity of Ca-binding sites in proteins: the 5-fold site in an icosahedral virus | |
Feng | New statistical potentials for improved protein structure prediction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050215 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070925 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071218 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080204 |
|
A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20080325 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20080526 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20080603 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090707 |
|
AA92 | Notification that decision to refuse application was cancelled |
Free format text: JAPANESE INTERMEDIATE CODE: A971092 Effective date: 20090721 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090804 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20091123 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100105 |